Michael Roguska

USPTO Granted Patents = 20 (Patent Applications = 15)

CIPO Patents = 2 (Patent Applications = 9)

EPO Patents = 7 (Patent Applications = 14)

Average Co-Inventor Count = 8.3

ph-index = 9

Forward Citations = 634(Granted Patents)

Location History:

Cambridge, MA (US) (2016 - 2018)
Ashland, MA (US) (2005 - 2020)
Old Orchard Beach, ME (US) (2019 - 2020)

Company Filing History:

Abbott Laboratories Corporation

Abb Vie Deutschland Gmbh & Co. Kg

patents

Years Active: 2005-2020

Loading Chart...

20 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10865237 - Nucleic acids encoding anti-Factor P antibodies (2020-12-15),

2. 10537648 - Compositions and methods for visualization of the vitreous (2020-01-21),

3. 10407496 - Compositions and methods for antibodies targeting complement protein C5 (2019-09-10),

4. 10385127 - Compositions and methods for antibodies targeting EPO (2019-08-20),

5. 10106605 - Compositions and methods for antibodies targeting Epo (2018-10-23),

6. 9988440 - Compositions comprising antibodies targeting factor P (2018-06-05),

7. 9365646 - Compositions and methods for antibodies targeting EPO (2016-06-14),

8. 9051365 - Antibodies that bind factor P (2015-06-09),

9. 9035030 - Human antibodies that bind the P40 subunit of human IL-12 and methods for using the same (2015-05-19),

10. 8883158 - Compositions and methods for antibodies targeting complement protein C5 (2014-11-11),

11. 8865174 - Methods of treatment using human antibodies that bind IL-12 (2014-10-21),

12. 8765918 - Human antibodies that bind human interleukin-12 (2014-07-01),

13. 8629257 - IL-12/p40 binding proteins (2014-01-14),

14. 8324350 - Dual-specific IL-1α/IL-1β antibodies (2012-12-04),

15. 8241628 - Compositions and methods for antibodies targeting complement protein C5 (2012-08-14),

Title: Michael Roguska: A Visionary Inventor Pushing Technological Boundaries

Introduction:

Michael Roguska, a visionary inventor hailing from Ashland, MA (US), has made significant contributions to the world of innovation with his prolific work in the field of technology. With an impressive 20 patents under his belt, Roguska stands out as a trailblazer dedicated to pushing the boundaries of what is possible in the realm of inventions.

Latest Patents:

1. Nucleic acids encoding anti-Factor P antibodies: Roguska's invention focuses on antibodies that bind to complement Factor P, offering potential therapeutic applications.

2. Compositions and methods for visualization of the vitreous: This patent provides solutions for rendering the vitreous cavity visible during surgical procedures, revolutionizing the treatment of structural disorders in the eye.

Career Highlights:

Roguska has left an indelible mark on the industry, having worked with prestigious companies such as Novartis AG and Abbott GmbH & Co. Kg. His innovative spirit and drive for excellence have fueled groundbreaking advancements in the field of technology.

Collaborations:

Throughout his career, Roguska has collaborated with esteemed colleagues such as Igor Splawski and Jochen G. Salfeld, enriching his projects with diverse expertise and fostering a culture of innovation and collaboration.

Conclusion:

In conclusion, Michael Roguska emerges as a visionary inventor whose passion for innovation and dedication to technological advancements have positioned him as a pioneer in the world of inventions. His remarkable contributions, exemplified by his numerous patents and influential collaborations, underscore his status as a transformative figure in the realm of technology, shaping the future of innovation for generations to come.

This text is generated by artificial intelligence and may not be accurate.